Community Pharmacy Quality Scheme: 2019/20 high risk medicines audit report – Lithium, methotrexate, amiodarone and phenobarbital

Document first published:
Page updated:
Topic:
,
Publication type:

This report details the results and findings of the 2019/20 high risk medicines audit report for lithium, methotrexate, amiodarone and phenobarbital and makes recommendations on further actions.

Link

Community Pharmacy Quality Scheme: 2019/20 high risk medicines audit report - Lithium, methotrexate, amiodarone and phenobarbital

Community Pharmacy Quality Scheme: 2019/20 high risk medicines audit report - Lithium, methotrexate, amiodarone and phenobarbital

NHS England is not responsible for content on external websites.